| 3UYS |
2.3 |
Crystal structure of apo human ck1d |
| 3UYT |
2.0 |
crystal structure of ck1d with PF670462 from P1 crystal form |
| 3UZP |
1.94 |
crystal structure of ck1d with PF670462 from P21 crystal form |
| 4HGT |
1.8 |
Crystal structure of ck1d with compound 13 |
| 4HNF |
2.07 |
Crystal structure of ck1d in complex with pf4800567 |
| 4KB8 |
1.95 |
CK1d in complex with 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE ligand |
| 4KBA |
1.98 |
CK1d in complex with 9-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine inhibitor |
| 4KBC |
1.98 |
CK1d in complex with {4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}METHANOL inhibitor |
| 4KBK |
2.1 |
CK1d in complex with (3S)-3-{4-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]pyridin-2-yl}morpholine inhibitor |
| 4TN6 |
2.41 |
CK1d in complex with inhibitor |
| 4TW9 |
2.4 |
Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation |
| 4TWC |
1.7 |
2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of CK1d/e |
| 5IH4 |
1.9 |
Human Casein Kinase 1 isoform delta apo (kinase domain) |
| 5IH5 |
2.25 |
Human Casein Kinase 1 isoform delta (kinase domain) in complex with Epiblastin A |
| 5IH6 |
2.3 |
Human Casein Kinase 1 isoform delta (kinase domain) in complex with Epiblastin A derivative |
| 5MQV |
2.154 |
Crystal structure of human Casein Kinase I delta in complex with 4-(2,5-Dimethoxyphenyl)-N-(4-(5-(4-fluorphenyl)-2-(methylthio)-1H-imidazol-4-yl)-pyridin-2-yl)-1-methyl-1H-pyrrole-2-carboxamide |
| 5OKT |
2.13 |
Crystal structure of human Casein Kinase I delta in complex with IWP-2 |
| 5W4W |
1.99 |
Identification and Profiling of a Selective and Brain Penetrant Radioligand for In Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors |
| 6F1W |
1.864 |
Crystal structure of human Casein Kinase I delta in complex with compound 31a |
| 6F26 |
1.83 |
Crystal structure of human Casein Kinase I delta in complex with compound 31b |
| 6GZM |
1.59 |
Crystal Structure of Human CKIdelta with A86 |
| 6HMP |
2.039 |
Crystal structure of human Casein Kinase I delta in complex with a photoswitchable 2-Azoimidazole-based Inhibitor (compound 3) |
| 6HMR |
1.782 |
Crystal structure of human Casein Kinase I delta in complex with a photoswitchable 2-Azothiazole-based inhibitor (compound 2) |
| 6PXN |
1.551 |
Human Casein Kinase 1 delta Tau mutant (R178C) |
| 6PXO |
2.0 |
Human Casein Kinase 1 delta (anion-free crystallization conditions) |
| 6PXP |
2.35 |
Human Casein Kinase 1 delta Site 2 mutant (K171E) |
| 6RCG |
1.4 |
Crystal structure of Casein kinase 1 delta (CK1 delta) complexed with SR3029 inhibitor |
| 6RCH |
1.45 |
Crystal structure of Casein kinase I isoform delta (CK1 delta) complexed with SR4133 inhibitor |
| 6RU6 |
2.05 |
Crystal structure of Casein Kinase I delta (CK1d) in complex with monophosphorylated p63 PAD1P peptide |
| 6RU7 |
2.08 |
Crystal structure of Casein Kinase I delta (CK1d) in complex with double phosphorylated p63 PAD2P peptide |
| 6RU8 |
1.92 |
Crystal structure of Casein Kinase I delta (CK1d) in complex with triple phosphorylated p63 PAD3P peptide |
| 7NZY |
1.85 |
Crystal structure of human Casein Kinase I delta in complex with CGS-15943 |
| 7P7F |
1.96 |
Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 1 |
| 7P7G |
1.7 |
Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 2 and 3 |
| 7P7H |
2.4 |
Crystal structure of Casein Kinase I delta (CK1d) with alphaG-in conformation |
| 7QR9 |
2.3 |
Crystal structure of CK1 delta in complex with PK-09-82 |
| 7QRA |
2.4 |
Crystal structure of CK1 delta in complex with VN725 |
| 7QRB |
2.6 |
Crystal structure of CK1 delta in complex with PK-09-129 |
